Prognostic significance of advanced lung cancer inflammation index in resectable pancreatic cancer: A retrospective study

Table 2 Baseline information between high advanced lung cancer inflammation index group and low advanced lung cancer inflammation index group

Characteristic	Low ALI (n = 233)	High ALI (n = 378)	P value
Age (years)	61 + 12	62 + 11	0.508
Sex			0.418
Male	136 (58.4)	208 (55.0)
Female	97 (41.6)	170 (45.0)
Body mass index (kg/m2)	22.7 + 3.9	23.7 + 4.3	< 0.01
Smoking	54 (23.2)	94 (24.9)	0.635
Drinking	35 (15.0)	74 (19.6)	0.153
Hypertension	76 (32.6)	97 (25.7)	0.064
Type 2 diabetes mellitus	67 (28.8)	110 (29.1)	0.927
Albumin (g/L)	41.0 + 7	42.6 + 6.2	< 0.01
Neutrophils (× 109/L)	4.7 + 2.3	3.4 + 1.4	< 0.01
Lymphocytes (× 109/L)	1.2 + 0.5	1.8 + 0.7	< 0.01
ALI	24.7 + 10.9	50.1 + 24.0	< 0.01
Tumor location			< 0.01
Pancreatic head and neck	143 (61.4)	172 (45.5)
Pancreatic body and tail	90 (38.6)	206 (54.5)
TNM stage			0.691
I	116 (49.8)	190 (50.3)
II	57 (24.5)	101 (26.7)
III	60 (25.8)	87 (23.0)
Tumor size	3.5 + 1.9	3.5 + 2	0.830

Continuous variables are expressed as median and interquartile range, n (%). ALI: Advanced lung cancer inflammation index.